Hims & Hers Stock Plummets: Is the Weight Loss Party Over

• Hims & Hers reported a net loss of $92 million in Q1, a significant increase from the previous year.
• The company's stock price has dropped nearly 13% following the announcement.
• Hims & Hers is shifting away from compounded GLP-1s, impacting revenue per subscriber.
• Novo Nordisk previously raised concerns about Hims & Hers' compounded drug practices and patient safety.

Not a Vibe: The Numbers Don't Lie

Okay, so like, I saw the Hims & Hers news, and it's not exactly giving 'rise and shine' vibes. A $92 million loss? That's a lot of lip kits, you know? They're blaming it on cutting back the compounded GLP-1s, which, let's be real, was kinda sus anyway. Remember when I said 2024 was about realizing stuff? Guess Hims & Hers is realizing some stuff too. Revenue being up only 4%? That's like, barely keeping up with inflation. My businesses always need to be on the uptick.

Bye, Bye Copycats: A GLP-1 Glow Down

So, Hims & Hers was selling, like, 'inspired' versions of Wegovy. You know, a dupe. And Novo Nordisk was not here for it. They sued them, basically saying it was dangerous and illegal. Can you imagine getting sued by a pharmaceutical giant? That's, like, the opposite of a 'billionaire baddie' move. Now, they're partnering with Novo to sell the real Wegovy. It's like when I had to pivot from Kylie Lip Kits to Kylie Cosmetics. Gotta stay legit, you know? Speaking of legit, have you heard about Trump Suspends Jones Act Amid Iran War Fuel Price Surge? It's a totally different story, but also about regulations and stuff.

Patient Safety: More Important Than a Quick Buck

Okay, real talk: patient safety is everything. Novo Nordisk said that Hims & Hers was putting people at risk with those compounded drugs. And honestly, that's just not cute. As someone with a huge platform, I have to be super careful about what I promote. I would never want to risk my fans' health for a quick buck. I mean, 'realizing stuff' is about accountability too, right?

Citi's Shady Outlook: Is This The End?

Even the analysts at Citi are like, 'Meh, it's mixed.' That's never a good sign. They said the second quarter outlook was below their estimates. Ouch. It sounds like they're going through a 'transition' phase. Honestly, transitions are hard. But they can also be a chance to come back stronger. Remember my hair transformations? Sometimes you gotta shave it all off to grow it back even better. But you do you boo.

Branding is Everything: Authenticity Always Wins

This whole situation just reminds me that branding is everything. You can't just sell a cheap copycat version of something and expect to get away with it. People want authenticity. They want quality. They want the Kylie Jenner stamp of approval. And honestly, sometimes you gotta take the L and learn from it. It's about what you can do for you, you know?

Future Forecast: Will Hims & Hers Rise and Shine Again

So, what's next for Hims & Hers? They're projecting up to $3 billion in revenue for the year. That's still a lot of money. But they need to regain trust and focus on quality products. Maybe a collab with Kylie Cosmetics? Just kidding… unless? Ultimately, whether they'll "rise and shine" again depends on whether they can clean up their act and put patient safety first. We can all stay tuned. I'm sure their next move will make waves across the industry.